Hepatitis C Treatment Knowledge and Practice Among Family Medicine Physicians in Wisconsin During the Current Hepatitis C Epidemic.
Authors:
- journal article
- Vol. 120 (2) , 106-113
Abstract
Curative treatment for hepatitis C virus (HCV) exists, making elimination of HCV possible. However, most people with HCV have not received treatment. One barrier is limited access to treatment providers. HCV treatment can be effectively provided by primary care providers and, since 2017, Wisconsin Medicaid allows nonspecialists to prescribe treatment. We surveyed family medicine physicians in Wisconsin to evaluate capacity for the provision of HCV treatment. We mailed a survey to family medicine physicians in Wisconsin from June 25, 2018 through September 7, 2018. Physicians were asked whether they prescribe HCV treatment and about their knowledge regarding HCV treatment and relevant statewide Medicaid policy. Using multivariable logistic regression, we evaluated physician characteristics associated with prescribing HCV treatment. Of 1,333 physicians surveyed, 600 (45%) responded. Few respondents reported prescribing HCV treatment independently (1%; n = 4) or in consultation with a specialist (6%; n = 35). Only 6% (n = 36) reported having a "great deal" of knowledge about HCV treatment. Most (86%; n = 515) were not aware that family medicine physicians can now prescribe HCV treatment covered by Medicaid. Physicians who practiced in offices affiliated with health systems were less likely to prescribe HCV treatment than physicians who practiced in an independent office or a Rural Health Clinic. Among family medicine physicians in Wisconsin, experience with and knowledge of HCV treatment was limited. Developing knowledge and skills among primary care providers is needed to expand treatment access and make progress toward HCV elimination. Studies are needed to evaluate treatment access in primary care offices affiliated with health systems.Keywords
This publication has 13 references indexed in Scilit:
- Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017Clinical Gastroenterology and Hepatology, 2020
- Treatment Outcomes of Hepatitis C-Infected Patients in Specialty Clinic vs. Primary Care Physician Clinic: A Comparative AnalysisGastroenterology Research and Practice, 2019
- Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort StudyOpen Forum Infectious Diseases, 2018
- Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014American Journal of Public Health, 2018
- Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist ProvidersAnnals of Internal Medicine, 2017
- Rising Mortality Associated With Hepatitis C Virus in the United States, 2003–2013Clinical Infectious Diseases, 2016
- Increases in Hepatitis C Virus Infection Related to Injection Drug Use Among Persons Aged ≤30 Years — Kentucky, Tennessee, Virginia, and West Virginia, 2006–20122015
- Provider Workforce Assessment in a Rural Hepatitis C EpidemicJournal of Primary Care & Community Health, 2014
- Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.2012
- Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care ProvidersNew England Journal of Medicine, 2011